| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3244849
Max Phase: Preclinical
Molecular Formula: C25H30N6O5
Molecular Weight: 494.55
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCOC(=O)C[C@H](NC(=O)c1ccc(NCc2ccc3nc(N)nc(N)c3c2C)cc1)C(=O)OCC
Standard InChI: InChI=1S/C25H30N6O5/c1-4-35-20(32)12-19(24(34)36-5-2)29-23(33)15-6-9-17(10-7-15)28-13-16-8-11-18-21(14(16)3)22(26)31-25(27)30-18/h6-11,19,28H,4-5,12-13H2,1-3H3,(H,29,33)(H4,26,27,30,31)/t19-/m0/s1
Standard InChI Key: GBLLLPBOUIEBSM-IBGZPJMESA-N
Associated Targets(non-human)
Dihydrofolate reductase 2343 Activities
Dihydrofolate reductase 93 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 494.55 | Molecular Weight (Monoisotopic): 494.2278 | AlogP: 2.33 | #Rotatable Bonds: 10 |
| Polar Surface Area: 171.55 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: | CX Basic pKa: 7.86 | CX LogP: 2.24 | CX LogD: 1.87 |
| Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.31 | Np Likeness Score: -0.73 |
References
| 1. Hynes JB, Eason DE, Garrett CM, Colvin PL.. (1977) Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids., 20 (4): [PMID:850245] [10.1021/jm00214a030] |
Source
Source(1):